Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Neuroectodermal Olfactory Neuroblastoma: A Nasal Cavity Cancer

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Jan 8, 2025

What is Neuroectodermal Olfactory Neuroblastoma?

Neuroectodermal Olfactory Neuroblastoma is a rare cancer that originates in the nasal cavity, potentially impairing the sense of smell. It can invade nearby tissues, including the eyes, brain, neck, lungs, or bones. This cancer accounts for approximately 3% of all nasal cavity tumours and most commonly occurs between the ages of 50 and 70.

Causes

The development of Olfactory Neuroblastoma may be influenced by both environmental and genetic factors:

1. Chemical Exposure:

Exposure to substances such as tobacco smoke, glues, nickel, cadmium, wood dust, wheat, and formaldehyde increases the risk.

2. Genetic Mutations:

Inherited genetic factors or DNA alterations, particularly involving chromosomes 2, 5, 6, 7, and 20, may contribute to the formation of this rare malignancy.

Signs and Symptoms

Common signs and symptoms include:

  • Nosebleeds.
  • Loss of smell.
  • Nasal congestion or stuffy nose.
  • Pain in the nose and face.

Diagnosis

Diagnosing Neuroectodermal Olfactory Neuroblastoma requires a comprehensive approach:

1. Imaging Tests:

CT scans or MRIs are used to determine the tumour’s location, size, and blood supply.

2. Biopsy:

A small tissue sample is taken from the tumour and analysed under a microscope.

3. Immunohistochemistry:

This specialised test helps differentiate Olfactory Neuroblastoma from other types of tumours.

Treatment Options

Treatment often involves a combination of surgical and therapeutic methods:

1. Surgery:

The primary approach is the surgical removal of the tumour and any affected nearby tissues.

2. Radiation Therapy:

Frequently combined with surgery to enhance the effectiveness of treatment.

3. Chemotherapy:

Used in advanced or metastatic cases to target and destroy cancer cells.

Prognosis:

The survival rate varies widely, ranging from 50% to 90%, depending on the tumour stage at diagnosis and the treatment approach.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousOur New Resource Page for Small Cell Carcinoma of the Ovary, Hypercalcemic Type
NextOur New Resource Page for Neuroectodermal Olfactory Neuroblastoma

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter